Kala Pharmaceuticals, Inc.
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

7 May 2021

Issue date:

26 Aug 2021